Sam Spigelman, MD

@DeantheDream6 Contact me . Been a long time and CONGRATULATIONS on your success!!!!!

psychedelic soul music :) #music #Rock #psychedelic #NewMusic #Indierock

#SUO24 @eugene_pietzak The current state of BCG unresponsive NMIBC: - Already FDA approved - Likely will be FDA approved in the near future - Off-label chemotherapy @urotoday

@MAWildgust @JNJInnovMed @jonathanpentel @par_onc @MundleSuneel Marvelous to see old friends at Gustave Roussy . A big shout out to both Yohann Loriot and to our fantastic colleague Mattias 👍👍👍.

Amazing time in Paris meeting with doctors at IGR and Institute Curie, discussing drug development in solid tumors. And, the amazing @JNJInnovMed French team. Thank you @jonathanpentel for the warm welcome of your team! We have more to do! #MyCompany

Congratulations @jteoh_hk on this inspiring scientific meeting; a vivid reminder of the collective global pursuit of scientific advancement @CUHKMedicine @IBCG_BladderCA

@MAWildgust @jillfeldman4 @JNJInnovMed I am also humbled

I am humbled to work with patients and patient advocates. I had a chance to talk with @jillfeldman4 during a meeting with my @JNJInnovMed colleagues on the importance of their voice. Jill, you inspire me! We hold your voice and lived experience close in all we do. #MyCompany

@MAWildgust Another win for prostate cancer patients !

Delighted to announce US FDA approval of AKEEGA (Dual Action Tablet of Niraparib and Zytiga) for patients with mCRPC prostate cancer with BRCA alterations. prnewswire.com/news-releases/…

Great results for Erdafitinib in FGFR +ve non muscle invasive bladder cancer with Siamak Daneshmand . Great Data #GU23

@UroDocAsh @NEJM @AtlanticUrology just the best from the one of the best

Congratulations Neal! atlanticurologyclinics.com/in-the-news/dr… @NEJM @AtlanticUrology

OOOpppsss.... @Uroweb @EAU_Uroonco @InfoAeu @GUOaeu @MariaJRibal FDA Does Not Approve Vicinium for BCG-unresponsive NMIBC targetedonc.com/view/fda-does-… a través de @targetedonc

Timely diagnosis is critical for rare diseases like #ALamyloidosis. Announcing the Improving Detection of AL Amyloidosis (IDEA) #QuickFireChallenge: submit ideas for optimizing detection & early diagnosis of this rare disorder jji.jnj/IDEA #AmyloidosisAwarenessMonth

SUB-urothelial DUrvalumab injEction-1 (SUBDUE-1) - A #ClinicalTrial for the novel administration of immunotherapy for #BladderCancer. Dickon Hayne @uwanews joins @UroDocAsh @MDAndersonNews to discuss the results on UroToday > bit.ly/3tuOOO7 @ANZUPtrials

I am pleased to share our last platinum priority paper from collaborative work: Molecular Characterization of Residual Bladder Cancer after Neoadj Pembrolizumab @ewanagibb @JoepJdeJong @pcvblack @Roland3097 @DanieleRaggi83 @LauraLmar89 #PURE01 @EUplatinum europeanurology.com/article/S0302-…

Fantastic research!!. Thank you Dr. N

1/5 Tweetorial 🚨⭐️What a great precision medicine story ! 🚨First came the NTRK fusion story 👉 Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children @NEJM @DavidHongMD @DHymanMD @alexdrilon @OncoAlert @FAndreMD nejm.org/doi/full/10.10…

@UroDocAsh @ASCO Agree with Ashish!!

Not the most intuitive platform @ASCO #GU21 meetinglibrary.asco.org/browse-meeting…

@garysteinbergmd @saumyg @RutgersCancer @USC_Urology @SanamLadi @syan_sumeet @siadaneshmand @BCAN_NCT @RyanWerntzMD Absolutely agree with Gary

@saumyg @RutgersCancer @USC_Urology @SanamLadi @syan_sumeet @siadaneshmand I disagree Choose your neobladder patients carefully #gdsfellows #bladdercancer @BCAN_NCT @RyanWerntzMD

New📰: @RutgersCancer @USC_Urology @SanamLadi @syan_sumeet @siadaneshmand: Every cystectomy candidate is a potential neobladder candidate and deserves a full discussion of risks/benefits - Retention in males is rare (7%) and 17% will cath 1-2x/day - Risk ⬆️ with time and BMI>27

JUST RELEASED: We've published w/ @ASCO our latest recommendations to expand patient access to cancer clinical trials by further broadening eligibility criteria. For more information: trib.al/KWlBGf4 #WhatFriendsDoes #clinicaltrials #FDA @CCR_AACR

🚨⭐️The new version V3.0 is out ➡️ The Swiss Cheese Respiratory Pandemic Defense Against #COVID19 model from @MackayIM 👏🏼 includes #vaccines 👉🏼Personal +shared responsibilities✅ 👉🏼Multiple layers improve success✅ #InThisTogether #EndCovid